Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Esophageal Varices-I: Introduction01:24

Esophageal Varices-I: Introduction

2.0K
Esophageal varices are dilated, tortuous veins which are found mainly in the submucosa of the lower esophagus but which may also appear higher up or extend into the stomach. They develop due to increased pressure in the portal venous system, often as a result of liver cirrhosis. This condition scars and damages the liver, impeding normal blood flow through the portal vein. To compensate, blood seeks alternative pathways, forming fragile new vessels (varices) in the esophagus and stomach. These...
2.0K
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

744
Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
744
Peptic Ulcer01:27

Peptic Ulcer

20
Peptic ulcers are erosive lesions of the gastric or duodenal lining, most commonly caused by Helicobacter pylori infection. This Gram-negative, helical bacterium has adapted to survive the stomach’s acidic environment by producing urease, which converts urea into ammonia and carbon dioxide. The ammonia neutralizes gastric acid in the bacterium’s immediate environment, allowing colonization of the gastric mucosa. H. pylori attaches to mucus-secreting epithelial cells, penetrates the...
20
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

1.6K
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
1.6K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

1.0K
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
1.0K
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies01:28

Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies

761
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
761

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

De Novo Autoimmune Hepatitis after COVID-19 Infection in an Unvaccinated Patient.

Case reports in hepatology·2023
Same author

Ecological Study of Variability in the Relationship between Liver Cancer Mortality and Racial Residential Segregation.

International journal of environmental research and public health·2021
Same author

Prevalence and Susceptibility to Hepatitis B virus and the Need for Community Health Education in Milwaukee's Hmong Community.

Journal of racial and ethnic health disparities·2021
Same author

Hepatitis B Screening and Awareness in the Milwaukee Hmong Community.

WMJ : official publication of the State Medical Society of Wisconsin·2021
Same author

Position 2: Transarterial Radioembolization Should Be the Primary Locoregional Therapy for Unresectable Hepatocellular Carcinoma.

Clinical liver disease·2020
Same author

Real-world experiences with direct-acting antiviral agents for chronic hepatitis C treatment.

Journal of viral hepatitis·2019

Related Experiment Video

Updated: Mar 23, 2026

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
02:14

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Published on: August 1, 2025

2.0K

Nonvariceal Upper Gastrointestinal Bleeding.

Syed Irfan-Ur Rahman1, Kia Saeian2

  • 1Department of Medicine, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA.

Critical Care Clinics
|March 27, 2016
PubMed
Summary
This summary is machine-generated.

Managing nonvariceal upper gastrointestinal bleeding in the ICU requires prompt assessment and hemodynamic stabilization. Risk scores aid triage, while emerging endoscopic techniques need further study.

Keywords:
Blatchford scoreEndoscopyNonsteroidal antiinflammatory drugsNonvariceal upper gastrointestinal bleedPeptic ulcer diseaseProton pump inhibitorRockall score

More Related Videos

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
04:09

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

1.5K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.3K

Related Experiment Videos

Last Updated: Mar 23, 2026

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices
02:14

Underwater Endoscopic Injection Sclerotherapy for Gastroesophageal Varices

Published on: August 1, 2025

2.0K
Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices
04:09

Endoscopic Injection Sclerotherapy Assisted by Cyanoacrylate and Clips for Gastroesophageal Varices

Published on: June 13, 2025

1.5K
Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy
07:10

Measurement of the Hepatic Venous Pressure Gradient and Transjugular Liver Biopsy

Published on: June 18, 2020

23.3K

Area of Science:

  • Gastroenterology
  • Critical Care Medicine

Background:

  • Nonvariceal upper gastrointestinal bleeding (NVUGIB) is a critical condition requiring immediate management in intensive care units (ICUs).
  • Effective management hinges on identifying causative factors and ensuring hemodynamic stability.

Purpose of the Study:

  • To outline the essential steps in managing NVUGIB within the ICU setting.
  • To highlight the utility of risk stratification tools and the need for evaluating new endoscopic interventions.

Main Methods:

  • Focused patient history and physical examination to determine inciting factors.
  • Respiratory assessment and hemodynamic monitoring.
  • Application of risk stratification scores (Blatchford, Rockall) for triage and management decisions.

Main Results:

  • Prompt identification of inciting factors and hemodynamic instability is crucial.
  • Fluid resuscitation and blood transfusions are key interventions for instability.
  • Risk stratification tools can aid in efficient patient management.

Conclusions:

  • Vigilance and a systematic approach are paramount for managing NVUGIB in the ICU.
  • Further research is necessary to establish the safety and efficacy of novel endoscopic techniques for NVUGIB.